39069-52-8,MFCD06201849
Catalog No.:AA00C08T

39069-52-8 | N4,N6-Dicyclopentyl-2-(methylthio)-5-nitropyrimidine-4,6-diamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%
in stock  
$98.00   $68.00
- +
10mg
≥98%
in stock  
$173.00   $121.00
- +
25mg
≥98%
in stock  
$409.00   $286.00
- +
50mg
99%
in stock  
$745.00   $522.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00C08T
Chemical Name:
N4,N6-Dicyclopentyl-2-(methylthio)-5-nitropyrimidine-4,6-diamine
CAS Number:
39069-52-8
Molecular Formula:
C15H23N5O2S
Molecular Weight:
337.4404
MDL Number:
MFCD06201849
SMILES:
CSc1nc(NC2CCCC2)c(c(n1)NC1CCCC1)[N+](=O)[O-]
Properties
Computed Properties
 
Complexity:
368  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
5  
XLogP3:
5.2  

Literature

Title: Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.

Journal: Alcoholism, clinical and experimental research 20121001

Title: Positive allosteric modulation of the GABA(B) receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization.

Journal: Alcohol (Fayetteville, N.Y.) 20120801

Title: Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms.

Journal: Pharmacology, biochemistry, and behavior 20111001

Title: Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.

Journal: The Journal of pharmacology and experimental therapeutics 20110901

Title: The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward.

Journal: Addiction biology 20110701

Title: The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.

Journal: British journal of pharmacology 20110701

Title: Administration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference.

Journal: Behavioural brain research 20110101

Title: In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).

Journal: Neuropharmacology 20110101

Title: Sleep-deprivation induces changes in GABA(B) and mGlu receptor expression and has consequences for synaptic long-term depression.

Journal: PloS one 20110101

Title: Role of the GABA(B) receptor in alcohol-seeking and drinking behavior.

Journal: Alcohol (Fayetteville, N.Y.) 20091101

Title: Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.

Journal: European journal of pharmacology 20090128

Title: Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization.

Journal: Neuropharmacology 20081201

Title: Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen.

Journal: Alcoholism, clinical and experimental research 20080901

Title: Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats.

Journal: The Journal of pharmacology and experimental therapeutics 20080701

Title: Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABA B receptors.

Journal: Bioorganic & medicinal chemistry letters 20071115

Title: Allosteric modulators of GABA(B) receptors: mechanism of action and therapeutic perspective.

Journal: Current neuropharmacology 20070901

Title: Reducing effect of the positive allosteric modulator of the GABA(B) receptor, GS39,783, on alcohol self-administration in alcohol-preferring rats.

Journal: Psychopharmacology 20070801

Title: GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation.

Journal: The Journal of pharmacology and experimental therapeutics 20070401

Title: GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070201

Title: Point mutations in the transmembrane region of GABAB2 facilitate activation by the positive modulator N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) in the absence of the GABAB1 subunit.

Journal: Molecular pharmacology 20061201

Title: The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo.

Journal: Journal of neurochemistry 20060301

Title: Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats.

Journal: European journal of pharmacology 20051121

Title: The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20051101

Title: Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.

Journal: Neuropharmacology 20050301

Title: GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent.

Journal: The Journal of pharmacology and experimental therapeutics 20050101

Title: Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.

Journal: The Journal of pharmacology and experimental therapeutics 20040901

Title: Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040601

Title: Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats.

Journal: Psychopharmacology 20040401

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 39069-52-8
Tags:39069-52-8 Molecular Formula|39069-52-8 MDL|39069-52-8 SMILES|39069-52-8 N4,N6-Dicyclopentyl-2-(methylthio)-5-nitropyrimidine-4,6-diamine
Catalog No.: AA00C08T
39069-52-8,MFCD06201849
39069-52-8 | N4,N6-Dicyclopentyl-2-(methylthio)-5-nitropyrimidine-4,6-diamine
Pack Size: 5mg
Purity: ≥98%
in stock
$98.00 $68.00
Pack Size: 10mg
Purity: ≥98%
in stock
$173.00 $121.00
Pack Size: 25mg
Purity: ≥98%
in stock
$409.00 $286.00
Pack Size: 50mg
Purity: 99%
in stock
$745.00 $522.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00C08T
Chemical Name: N4,N6-Dicyclopentyl-2-(methylthio)-5-nitropyrimidine-4,6-diamine
CAS Number: 39069-52-8
Molecular Formula: C15H23N5O2S
Molecular Weight: 337.4404
MDL Number: MFCD06201849
SMILES: CSc1nc(NC2CCCC2)c(c(n1)NC1CCCC1)[N+](=O)[O-]
Properties
Complexity: 368  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 23  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 2  
Rotatable Bond Count: 5  
XLogP3: 5.2  
Literature fold

Title: Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.

Journal: Alcoholism, clinical and experimental research20121001

Title: Positive allosteric modulation of the GABA(B) receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization.

Journal: Alcohol (Fayetteville, N.Y.)20120801

Title: Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms.

Journal: Pharmacology, biochemistry, and behavior20111001

Title: Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.

Journal: The Journal of pharmacology and experimental therapeutics20110901

Title: The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward.

Journal: Addiction biology20110701

Title: The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.

Journal: British journal of pharmacology20110701

Title: Administration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference.

Journal: Behavioural brain research20110101

Title: In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).

Journal: Neuropharmacology20110101

Title: Sleep-deprivation induces changes in GABA(B) and mGlu receptor expression and has consequences for synaptic long-term depression.

Journal: PloS one20110101

Title: Role of the GABA(B) receptor in alcohol-seeking and drinking behavior.

Journal: Alcohol (Fayetteville, N.Y.)20091101

Title: Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.

Journal: European journal of pharmacology20090128

Title: Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization.

Journal: Neuropharmacology20081201

Title: Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen.

Journal: Alcoholism, clinical and experimental research20080901

Title: Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats.

Journal: The Journal of pharmacology and experimental therapeutics20080701

Title: Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABA B receptors.

Journal: Bioorganic & medicinal chemistry letters20071115

Title: Allosteric modulators of GABA(B) receptors: mechanism of action and therapeutic perspective.

Journal: Current neuropharmacology20070901

Title: Reducing effect of the positive allosteric modulator of the GABA(B) receptor, GS39,783, on alcohol self-administration in alcohol-preferring rats.

Journal: Psychopharmacology20070801

Title: GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation.

Journal: The Journal of pharmacology and experimental therapeutics20070401

Title: GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20070201

Title: Point mutations in the transmembrane region of GABAB2 facilitate activation by the positive modulator N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) in the absence of the GABAB1 subunit.

Journal: Molecular pharmacology20061201

Title: The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo.

Journal: Journal of neurochemistry20060301

Title: Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats.

Journal: European journal of pharmacology20051121

Title: The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20051101

Title: Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.

Journal: Neuropharmacology20050301

Title: GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent.

Journal: The Journal of pharmacology and experimental therapeutics20050101

Title: Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.

Journal: The Journal of pharmacology and experimental therapeutics20040901

Title: Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20040601

Title: Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats.

Journal: Psychopharmacology20040401

Building Blocks More >
4063-48-3
4063-48-3
1,2-Bis(1,1,2,2-tetrafluoroethoxy)benzene
AA00C0F9 | MFCD03424468
37106-97-1
37106-97-1
4-[(2S)-3-(4-hydroxyphenyl)-2-(phenylformamido)propanamido]benzoic acid
AA00C0LS | MFCD00055768
35700-27-7
35700-27-7
15(S)-15-METHYL PROSTAGLANDIN E2
AA00C0SC | MFCD00216055
320-75-2
320-75-2
2-Bromo-4-fluoro-6-nitrophenol
AA00C0VK | MFCD03094182
268550-48-7
268550-48-7
tert-Butyl 1-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate
AA00C11Q | MFCD08461248
23606-16-8
23606-16-8
Tris(8-hydroxyquinolinato)erbium
AA00C19Q | MFCD03268285
302916-36-5
302916-36-5
Dde-phe-ol
AA00C1LC | MFCD06796886
252873-46-4
252873-46-4
3-Phenoxy-benzenesulfonyl chloride
AA00C1R4 | MFCD02089483
225939-36-6
225939-36-6
4-(Allyloxy)-3-ethoxybenzaldehyde
AA00C1VQ | MFCD02254126
2153-08-4
2153-08-4
2-Chloro-n-(4-ethoxyphenyl)acetamide
AA00C1ZU | MFCD00018908
Submit
© 2017 AA BLOCKS, INC. All rights reserved.